雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Paraneoplastic Neurologic Syndromes Keiko Tanaka 1,2 1Department of Animal Model Development, Brain Research Institute, Niigata University 2Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, School of Medicine Keyword: 傍腫瘍性神経症候群 , 悪性腫瘍 , 自己抗体 , 細胞傷害性T細胞 , 免疫チェックポイント阻害薬 , paraneoplastic neurologic syndrome , cancer , autoantibody , cytotoxic T cells , immune checkpoint inhibitors pp.755-762
Published Date 2023/6/1
DOI https://doi.org/10.11477/mf.1416202411
  • Abstract
  • Look Inside
  • Reference

Abstract

Paraneoplastic neurologic syndromes (PNS) are a group of neurological disorders that are possibly caused by immunological mechanisms triggered by an underlying tumor that involves every part of the nervous system. Autoantibodies were categorized according to the risk of cancer association. Antibodies against intracellular proteins are excellent markers for tumor detection, however, without functional roles in neuronal loss, the direct effector of neuronal damage is thought to be cytotoxic T cells. The frequently associated symptoms include limbic encephalitis, cerebellar ataxia and sensory neuronopathy. The associated tumors are mainly small-cell lung cancer, breast/ovarian/uterine cancers, and thymoma. Timely diagnosis, prompt immunotherapy, and treatment of the underlying tumor are essential for managing PNS. However, we need to be cautious about the high frequency of false-positive/negative results of antibodies using commercial antibody tests. This highlight the importance of the careful evaluation of clinical features. Recently, PNS emerged after immune check point inhibitor administration, and this became a subject of attention exploring its pathogenesis. Other basic studies to understand the immunological background of PNS have been progressing.


Copyright © 2023, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有